Table 3.

Classification of patients according to pathology status of [^99mTc]tilmanocept-identified SLNs, overall pathology nodal status, and calculated efficacy performance metrics

	Overall nodal pathology status (SLN and non-SLN), by patient
	Positive (with one or more nodes)	Negative
Pathology status of SLN, by patient
Positive (one or more nodes)	38 (true positive)	–
Negative (or no SLNs identified)	1 (false negative)	44 (true negative)

Performance metrics	Rate	95 % exact binomial CIa
False negative rate	0.0256	0.0006–0.1349
Negative predictive value	0.9778	0.8823– 0.9994
Overall accuracy	0.9880	0.9347– 0.9997

Data represent the intent-to-treat population (N = 83)

CI confidence interval, SLN sentinel lymph node

^aThe CI for the false negative rate is 95.03 %